The UN General Assembly Special Session (UNGASS) on drugs is fast approaching 2016 and is an important opportunity to conduct a thorough and objective assessment of the international drug control system. This session will discuss remaining challenges, as well as opportunities for the way forward – in particular towards rebalancing current drug policies towards the core UN values of public health, human rights and development
In March 2014, country delegations will gather at the United Nations Commission on Narcotic Drugs (CND) to review progress and challenges in international drug control since the agreement of a Political Declaration on drugs in 2009. Given that the Political Declaration aims to “eliminate or reduce significantly” the use, supply and demand of controlled drugs by 2019, this meeting represents an important opportunity for honest evaluation and an acknowledgement that these targets are not being achieved. With a United Nations General Assembly Special Session (UNGASS) on drugs just two years away, this is an important time for international drug control policy.
As the world prepares for the 2016 Special Session of the United Nations General Assembly on the World Drug Problem (UNGASS 2016), an increasing number of countries around the world now find the regime’s emphasis on punitive approaches to illicit drugs to be problematic and are asking for reform. In this moment of global disagreement, the Brookings project on Improving Global Drug Policy provides a unique comparative evaluation of the effectiveness and costs of international counternarcotics policies and best approaches to reform.
Preparations are gathering pace for the United Nations General Assembly Special Session (UNGASS) on drugs, to be held on the 19th to 21st April 2016 in New York. Following several months of discussion on procedural elements, attention is now focused on negotiating the content of the "short, substantive, concise and action-orientated outcome document comprising a set of operational recommendations" to be approved by the General Assembly next April. At the CND intersessional meeting on 12th June, countries and regional groups were invited to submit their first ideas for what could be included in this Outcome Document, by a deadline of 11th September.
On 19th to 21st April 2016, there will be a United Nations General Assembly Special Session (UNGASS) held in New York, dedicated to the issue of drug policy. The General Assembly is the highest policy making and representative organ of the United Nations (UN), and its infrequent Special Sessions focus on pertinent topics at the request of member states. The UNGASS on drugs has the potential to be a ground-breaking, open debate about the international drug control system – but there is much work to be done to ensure that it fulfils that potential.
At the annual UN General Assembly meeting held in New York, presidents from around the world have the chance to state their views on the key international issues of the day. Not surprisingly, the crisis in Syria, Iran’s pursuit of nuclear weapons and the Millennium Development Goals took center stage this year. Yet a careful viewing of the speeches of the Latin American presidents illustrates the growing voice of Latin American leaders calling for meaningful reform of drug control policies.
Kofi Annan Secretary General of the United Nations, Fernando Henrique Cardoso
05 November 2013
Each year, hundreds of thousands of people around the world die from preventable drug-related disease and violence. Millions of users are arrested and thrown in jail. Globally, communities are blighted by drug-related crime. Citizens see huge amounts of their taxes spent on harsh policies that are not working. But despite this clear evidence of failure, there is a damaging reluctance worldwide to consider a fresh approach. The Global Commission on Drug Policy is determined to help break this century-old taboo. See IDPC Press Release.
The United Nations General Assembly Special Session (UNGASS) on drugs in 2016 is intended to provide states with the opportunity to openly debate the future of international drug policies. An event at UN headquarters in New York discussed precisely what preparations are necessary to make sure the UNGASS accomplishes this objective.
Ahead of the High-Level Segment on the world drug problem to take place on 13th and 14th January 2014, the UNODC Executive Director, Yuri Fedotov, has released his "contributions" to the debate. This 19-page document is, in parts, refreshingly honest about the “unequal” progress that has been made since 2009 (with reductions in supply or demand for some drugs in some places being offset by increases elsewhere), the setbacks and new challenges, and the fact that “the overall magnitude of drug demand has not substantially changed at the global level”.
UN forums in recent years have witnessed more and more governments expressing their frustrations with the failing global war on drugs. This failure goes way beyond just the goals of drug control systems to reduce illicit drug production and use. The key driver of calls for change has been the catastrophic negative impacts of the war on drugs on public health, human rights, development and security.
In April 2016, representatives of the world’s nations will gather to evaluate drug policy in a United Nations General Assembly Special Session (UNGASS). While prohibitionist policies are still the norm, a rising tide of voices are demanding evidence based responses that respect human rights, promote public health, and reduce crime.
Just over one year away from the 2016 UNGASS, denying the reality that the drug policy landscape has fundamentally changed and that tensions with the UN drug conventions are occuring, is no longer a credible option. Secretary General Ban Ki-moon urged member states to use the 2016 UNGASS on drugs "to conduct a wide-ranging and open debate that considers all options." TNI calls for a special advisory group that should be tasked with recommending how to better deal with the contentious issues following the 2016 UNGASS, in preparation for the next UN high-level review in 2019.
Global disagreement over drug policies provides an important opportunity to reconsider the effectiveness of existing counternarcotics policies, address their problematic side effects, and propose evidence-based alternative strategies. Because of the differences in attitudes on drug policy around the world, a substantial revision of existing counternarcotics treaties is unlikely at UNGASS 2016. (See also: Improving global drug policy: Comparative perspectives and UNGASS 2016)
Senator Mark Golding, minister of justice, participated in a plenary session with several UN member states at the United Nations in a High Level Thematic Debate on International Drug Policy in preparation for the UN General Assembly Special Session on the World Drug Problem (UNGASS) scheduled for April 19-21 2016. Minister Golding highlighted Jamaica’s perspectives called for open and inclusive discussions, including the creation of an expert advisory group to review the United Nations drug policy control architecture.
Drug law reform continues developing in the right direction in several Latin American and Caribbean countries. In Jamaica, for example, a law legalizing the cultivation and consumption of ganja for medicinal, religious and research purposes came into force, as well as the decriminalisation of possession for personal use. Jamaica also spoke out at the UN Thematic Debate in New York. On May 7th, the minister addressed the UN High Level Thematic Debate on international drug policy, highlighting Jamaica’s perspectives on drug control policies and participating in a debate that encourages open and inclusive discussions. Amongst the outcomes Jamaica would like to see from UNGASS is “the establishment of an Expert Advisory Group to review the UN drug policy control architecture, its system-wide coherence, its treaty inconsistencies and its legal tension with cannabis regulations.”
Women of China - On Friday October 23, the Brookings-Tsinghua Center for Public Policy "Reform or Perseverance" panel discussion took place in Beijing, for experts to discuss findings from a recent evaluation into the effectiveness and costs of international drugs policy, ahead of next year's UN meeting on the "World Drug Problem" (UNGASS 2016).